Thyrocare Technologies sets record date for dividend; stock gains by 4 per cent

On Friday, the shares of Thyrocare Technologies gained by around 4.12 per cent after the company announced positive growth in quarterly results for Q2FY21.

On a consolidated basis, for Q2FY21, revenue increased by 31.83 per cent YoY to Rs 153.25 crore while net profit gained in Q2FY21 rose by 22.82 per cent to Rs 43.05 crore compared to Rs 35.05 crore gained in Q2FY20.

For FY21, the company also declared an interim dividend of Rs 10 per share with November 13, 2020, set as the record date.

On a YTD basis, the total revenue from COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) stood at Rs 71.01 crore, which accounts for 35.1 per cent of the total revenue from pathology business i.e. of Rs 202.94 crore.

The shares of Thyrocare Technologies jumped by more than 54 per cent since the beginning of October 2020 and by around 116 per cent on a YTD basis.

On Friday, the stock of the company was seen trading at Rs 1,175.85, up by 3.31 per cent or Rs 37.70 per share. Its 52-week high is Rs 1,212 and the 52-week low is Rs 410 on BSE.